These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 12237780

  • 1. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
    Martínez C, García-Martín E, Pizarro RM, García-Gamito FJ, Agúndez JA.
    Br J Cancer; 2002 Sep 09; 87(6):681-6. PubMed ID: 12237780
    [Abstract] [Full Text] [Related]

  • 2. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M, Shindo M, Shimada T.
    Drug Metab Dispos; 2001 Feb 09; 29(2):200-5. PubMed ID: 11159812
    [Abstract] [Full Text] [Related]

  • 3. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
    Zhu M, Zhao W, Jimenez H, Zhang D, Yeola S, Dai R, Vachharajani N, Mitroka J.
    Drug Metab Dispos; 2005 Apr 09; 33(4):500-7. PubMed ID: 15640381
    [Abstract] [Full Text] [Related]

  • 4. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
    Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, Hall SD.
    J Pharmacol Exp Ther; 1999 Sep 09; 290(3):1116-25. PubMed ID: 10454485
    [Abstract] [Full Text] [Related]

  • 5. Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.
    Voorman RL, Maio SM, Payne NA, Zhao Z, Koeplinger KA, Wang X.
    J Pharmacol Exp Ther; 1998 Oct 09; 287(1):381-8. PubMed ID: 9765359
    [Abstract] [Full Text] [Related]

  • 6. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM, Velez RL, von Moltke LL, Greenblatt DJ.
    Clin Pharmacol Ther; 1999 Nov 09; 66(5):461-71. PubMed ID: 10579473
    [Abstract] [Full Text] [Related]

  • 7. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
    Zhou-Pan XR, Sérée E, Zhou XJ, Placidi M, Maurel P, Barra Y, Rahmani R.
    Cancer Res; 1993 Nov 01; 53(21):5121-6. PubMed ID: 8221648
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of methoxymorpholinyl doxorubicin: potentiation by cytochrome P450 3A metabolism.
    Lu H, Waxman DJ.
    Mol Pharmacol; 2005 Jan 01; 67(1):212-9. PubMed ID: 15465924
    [Abstract] [Full Text] [Related]

  • 9. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
    Ekström G, Gunnarsson UB.
    Drug Metab Dispos; 1996 Sep 01; 24(9):955-61. PubMed ID: 8886604
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.
    Haaz MC, Rivory L, Riché C, Vernillet L, Robert J.
    Cancer Res; 1998 Feb 01; 58(3):468-72. PubMed ID: 9458091
    [Abstract] [Full Text] [Related]

  • 11. The use of human hepatocyte cultures to study the induction of cytochrome P-450.
    Kostrubsky VE, Ramachandran V, Venkataramanan R, Dorko K, Esplen JE, Zhang S, Sinclair JF, Wrighton SA, Strom SC.
    Drug Metab Dispos; 1999 Aug 01; 27(8):887-94. PubMed ID: 10421615
    [Abstract] [Full Text] [Related]

  • 12. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
    Zhang Y, Guo X, Lin ET, Benet LZ.
    Drug Metab Dispos; 1998 Apr 01; 26(4):360-6. PubMed ID: 9531525
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes.
    Postlind H, DanielsonA, Lindgren A, Andersson SH.
    Drug Metab Dispos; 1998 Apr 01; 26(4):289-93. PubMed ID: 9531513
    [Abstract] [Full Text] [Related]

  • 15. Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms.
    Pearce RE, Gotschall RR, Kearns GL, Leeder JS.
    Drug Metab Dispos; 2001 Dec 01; 29(12):1548-54. PubMed ID: 11717173
    [Abstract] [Full Text] [Related]

  • 16. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
    Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dréano Y, Menard C, Picart D, Berthou F.
    Chem Res Toxicol; 1997 Oct 01; 10(10):1205-12. PubMed ID: 9348445
    [Abstract] [Full Text] [Related]

  • 17. Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
    Fabre G, Julian B, Saint-Aubert B, Joyeux H, Berger Y.
    Drug Metab Dispos; 1993 Oct 01; 21(6):978-85. PubMed ID: 7905403
    [Abstract] [Full Text] [Related]

  • 18. The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.
    Fischer V, Rodríguez-Gascón A, Heitz F, Tynes R, Hauck C, Cohen D, Vickers AE.
    Drug Metab Dispos; 1998 Aug 01; 26(8):802-11. PubMed ID: 9698296
    [Abstract] [Full Text] [Related]

  • 19. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, Zanovello P.
    Cancer Res; 2000 Jun 15; 60(12):3232-8. PubMed ID: 10866316
    [Abstract] [Full Text] [Related]

  • 20. Properties and regional expression of a CYP3A-like protein in channel catfish intestine.
    James MO, Lou Z, Rowland-Faux L, Celander MC.
    Aquat Toxicol; 2005 May 15; 72(4):361-71. PubMed ID: 15848255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.